Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synergy CHC (SNYR) Cash & Equivalents (2016 - 2025)

Synergy CHC has reported Cash & Equivalents over the past 10 years, most recently at $2.6 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $2.6 million for Q4 2025, up 281.19% from a year ago — trailing twelve months through Dec 2025 was $2.6 million (up 281.19% YoY), and the annual figure for FY2025 was $2.6 million, up 281.19%.
  • Cash & Equivalents for Q4 2025 was $2.6 million at Synergy CHC, up from $1.0 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SNYR hit a ceiling of $2.6 million in Q4 2025 and a floor of $177882.0 in Q1 2025.
  • Median Cash & Equivalents over the past 3 years was $687920.0 (2024), compared with a mean of $977867.7.
  • Biggest five-year swings in Cash & Equivalents: grew 8.76% in 2024 and later skyrocketed 288.04% in 2025.
  • Synergy CHC's Cash & Equivalents stood at $632534.0 in 2023, then grew by 8.76% to $687920.0 in 2024, then skyrocketed by 281.19% to $2.6 million in 2025.
  • The last three reported values for Cash & Equivalents were $2.6 million (Q4 2025), $1.0 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.